Item 9 Labs Corp.
INLB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $2 | $3 | $2 | $2 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $3 | $4 | $3 | $4 |
| Property Plant & Equip (Net) | $25 | $26 | $24 | $22 |
| Goodwill | $58 | $58 | $58 | $58 |
| Intangibles | $11 | $11 | $11 | $12 |
| Long-Term Investments | $5 | $5 | $8 | $8 |
| Tax Assets | -$5 | -$5 | -$8 | -$8 |
| Other NC Assets | $10 | $15 | $18 | $15 |
| Total NC Assets | $109 | $110 | $112 | $107 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $112 | $114 | $115 | $111 |
| Liabilities | – | – | – | – |
| Payables | $7 | $7 | $6 | $6 |
| Short-Term Debt | $34 | $25 | $25 | $20 |
| Tax Payable | $0 | $1 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $13 | $14 | $6 |
| Total Curr. Liab. | $59 | $47 | $47 | $41 |
| LT Debt | $0 | $0 | $0 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $8 | $7 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $9 | $8 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $59 | $56 | $54 | $49 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$78 | -$72 | -$68 | -$65 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $53 | $58 | $60 | $62 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $112 | $114 | $115 | $111 |
| Net Debt | $34 | $25 | $25 | $27 |